Cape Analytics uses AI and geospatial imagery to provide instant property intelligence for buildings across the United States. Cape Analytics enables insurers and other property stakeholders to access valuable property attributes at time of underwritingwith the accuracy and detail that traditionally required an on-site inspection, but with the speed and coverage of property record pre-fill. Founded in 2014, Cape Analytics is backed by leading venture firms and comprised of computer vision and risk analysis experts. Learn more at www.capeanalytics.com.

Bolt Biotherapeutics is a start-up with compelling technology from Dr. Engleman?s Lab at Stanford University, which demonstrated complete cures in numerous cancer models. The company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company?s future leaders to help it further develop and bring to patients novel and curative biotherapies.